Wang Wl
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 10%
Papers in ⓘ
-
- Anesthesia and Neurotoxicity Research 3
- Co-authors
- William T. London (1 shared paper)Mark A. Feitelson (1 shared paper)Ching‐Yu Chen (1 shared paper)Yu‐Ju Chen (1 shared paper)Pan‐Chyr Yang (1 shared paper)Yih‐Leong Chang (1 shared paper)Alexey I. Nesvizhskii (1 shared paper)Y-Y Wu (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Journal of Allergy and Clinical Immunology (2 papers)Gut (2 papers)Cancer Research (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Wang Wl
40 papers receiving 463 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 108
- Hepatology 57
- Oncology 96
- Molecular Biology 217
- Epidemiology 103
Countries citing papers authored by Wang Wl
This map shows the geographic impact of Wang Wl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Wl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Wl more than expected).
Fields of papers citing papers by Wang Wl
This network shows the impact of papers produced by Wang Wl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Wl. The network helps show where Wang Wl may publish in the future.
Co-authors
The 25 scholars most cited alongside Wang Wl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 115 | |
| 2 | Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. | 1991 | 105 |
| 3 | 2012 | 43 | |
| 4 | 2019 | 29 | |
| 5 | 1996 | 23 | |
| 6 | 2009 | 19 | |
| 7 | 2019 | 16 | |
| 8 | 2009 | 14 | |
| 9 | 2019 | 13 | |
| 10 | [Studies on the chemical constituents of Melia azedarach L]. | 1991 | 12 |
| 11 | 2019 | 10 | |
| 12 | Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme | 2016 | 9 |
| 13 | 2009 | 8 | |
| 14 | Factors influencing the survival of Shigella in wastewater and irrigation water. | 1966 | 8 |
| 15 | Immunohistochemical demonstration of CCAAT/enhancer binding protein (C/EBP) in human liver tissues of various origin. | 1994 | 5 |
| 16 | 2017 | 5 | |
| 17 | 2007 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2008 | 3 | |
| 20 | 2023 | 3 |
About Wang Wl
Wang Wl is a scholar working on Biological Psychiatry, Developmental Neuroscience, Hepatology, Gastroenterology and Pathology and Forensic Medicine, having authored 44 papers that have together received 475 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Anesthesia and Neurotoxicity Research (3 papers), Cancer Mechanisms and Therapy (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related molecular mechanisms research (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (108 citations), Hepatology (57 citations), Oncology (96 citations), Molecular Biology (217 citations) and Epidemiology (103 citations). Wang Wl has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include William T. London, Mark A. Feitelson, Ching‐Yu Chen, Yu‐Ju Chen, Pan‐Chyr Yang, Yih‐Leong Chang, Alexey I. Nesvizhskii, Y-Y Wu, Hom‐Lay Wang and Bo Zhou. Their work appears in journals such as Annals of Oncology, Journal of Allergy and Clinical Immunology, Gut, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.